Detalles de la búsqueda
1.
Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up.
BMC Cancer
; 22(1): 652, 2022 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35698215
2.
THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents.
Haematologica
; 104(4): 756-765, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30262570
3.
B-cell precursor leukemias with MYC-rearrangement come into the limelight.
Haematologica
; 108(3): 659-660, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35484663
4.
Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
Haematologica
; 100(7): 935-44, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26001791
5.
Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia.
Haematologica
; 99(4): 706-14, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24241490
6.
Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome.
Br J Haematol
; 162(1): 98-106, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23594030
7.
Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials.
Blood
; 118(22): 5774-82, 2011 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-21940824
8.
Can anthocyanins improve maintenance therapy of Ph(+) acute lymphoblastic leukaemia?
Eur J Haematol
; 90(4): 291-300, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23294316
9.
X-linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL.
EMBO Mol Med
; 15(1): e14557, 2023 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36416169
10.
A Single Dose of PEG-Asparaginase at the Beginning of Induction Not Only Accelerates MRD Clearance but Also Improves Long-Term Outcome in Children with B-Lineage ALL.
Cancers (Basel)
; 15(23)2023 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38067249
11.
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study.
Blood
; 115(16): 3206-14, 2010 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-20154213
12.
NOTCH1 mutation, TP53 alteration and myeloid antigen expression predict outcome heterogeneity in children with first relapse of T-cell acute lymphoblastic leukemia.
Haematologica
; 102(7): e249-e252, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28360149
13.
SUV-measurements and patient-specific corrections in pediatric Hodgkin-lymphoma: is there a benefit for PPV in early response assessment by FDG-PET?
Pediatr Blood Cancer
; 59(3): 475-80, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22190514
14.
High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse.
Haematologica
; 96(11): 1627-35, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21828124
15.
Autologous purified peripheral blood stem cell transplantation compare to chemotherapy in childhood acute lymphoblastic leukemia after low-risk relapse.
Pediatr Blood Cancer
; 57(4): 654-9, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21584934
16.
Anthroposophic supportive treatment in children with medulloblastoma receiving first-line therapy.
J Pediatr Hematol Oncol
; 33(3): e105-8, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21368673
17.
Carboplatin and ototoxicity: hearing loss rates among survivors of childhood medulloblastoma.
Childs Nerv Syst
; 27(3): 407-13, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20931205
18.
Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses.
Br J Haematol
; 149(3): 399-409, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20230404
19.
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Blood
; 111(9): 4477-89, 2008 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18285545
20.
Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.
Eur J Nucl Med Mol Imaging
; 37(10): 1842-53, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20505933